Lantern Pharma
LTRN
LTRN
26 hedge funds and large institutions have $6.84M invested in Lantern Pharma in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
62% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 13
82% less call options, than puts
Call options by funds: $55K | Put options by funds: $311K
Holders
26
Holding in Top 10
–
Calls
$55K
Puts
$311K
Top Buyers
| 1 | +$70K | |
| 2 | +$61K | |
| 3 | +$23.4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.4K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$5K |
Top Sellers
| 1 | -$12K | |
| 2 | -$11.6K | |
| 3 | -$10.7K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$9.87K |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
-$9.56K |